Research and Markets: India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)

Research and Markets (http://www.researchandmarkets.com/research/gj92x9/india_coronary) has announced the addition of the "India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)" report to their offering.

The coronary stent market in India, which comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 million in 2012. DES accounts for bulk of sales in India. The bio-absorbable stent ABSORB has garnered a considerable traction despite its high cost compared with the other available DES.

The key players operating in the segment are Alvimedica, Abbott Vascular, a division of Abbott Laboratories ABT, Boston Scientific (NYSE : BSX, LSE : BSX), Biosensors Inc., Biotronik, JW Medical, Medtronic, Inc. MDT, Meril Life Sciences, MicroPort Scientific Corporation (HKG: 0853), Sahajanand Medical Technologies and Translumina Therapeutics.

The market has grown impressively supported by a rise in coronary angioplasties which has resulted from a surge in cardiovascular diseases (CVDs), augmented healthcare spending as well as an increase in number of interventional cardiologists and cath labs in government and private hospitals, including individual cath lab centres run by interventional cardiologists as well as new corporate hospitals.

The demand has surged as central and state governments capped reimbursement rates which enhanced affordability resulting in an increase in volume. The decrease in reimbursement rates has given an edge to Indian, Asian and some of the Europe-based mid-sized MNCs which sell stents at almost half the price of those sold by US companies.

In the US, the stents market has slumped significantly due to negative results from clinical studies suggesting that one-third of stent implants are unnecessary. However, in India these studies have not made an impact as most Indian cardiologists do not seem to have taken these clinical outcomes seriously.

India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)', is a market report that reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), market growth, pricing, competitive landscape and market share.

The research report covers 700 cath labs across the country. It analyses angioplasty procedures' (PCI and PTCA) data for the country with a detailed analysis at national, state, district, city and hospital levels. It provides PCI data of 550 hospitals from more than 150 cities.

Companies Mentioned

- Abbott Vascular, a division of Abbott Laboratories
- Alvimedica
- Biosensors Inc.
- Biotronik
- Boston Scientific
- JW Medical
- Medtronic Inc.
- Meril Life Sciences
- MicroPort Scientific Corporation
- Sahajanand Medical Technologies
- Translumina Therapeutics

For more information visit http://www.researchandmarkets.com/research/gj92x9/india_coronary

View source version on businesswire.com: http://www.businesswire.com/news/home/20150724005356/en/